Business
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference
PLYMOUTH MEETING, Pa., May 5, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to
About this update from Inovio Pharmaceuticals, Inc.
[{"type":"text","content":"PLYMOUTH MEETING, Pa., May 5, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Jacqueline Shea, Ph.D., President and CEO, will present at the 2023 RBC Capital Markets Global Healthcare Conference.\n2023 RBC Capital Markets Global Healthcare ConferenceDate: Wednesday, May 17, 2023Time: 4:05 PM ETFormat: Fireside Chat\nDuring the conference, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors.\nA webcast of the presentation will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. A replay of the webcast will be available for 90 days after the date of the presentation.\nAbout INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device, CELLECTRA®, to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com.\nContactsMedia: Jennie Willson (267) 429-8567 [email protected] Investors: Thomas Hong (267) 440-4298 [email protected]\n View original content:https://www.prnewswire.com/news-releases/inovio-to-present-at-the-2023-rbc-capital-markets-global-healthcare-conference-301816542.html\nSOURCE INOVIO Pharmaceuticals, Inc.","length":3079,"tagName":"div"}]